2093128-28-8
2093128-28-8
Chemical Structure
Pomalidomide-d3
Synonym(s): CC-4047-d3
- CAS No.: 2093128-28-8
- Formula:C13H8D3N3O4
- Molecular Weight:276.27
IUPAC Name: 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione-5,6,7-d3
InChIKey: UVSMNLNDYGZFPF-CBYSEHNBSA-N
SMILES: O=C1N(C2C(NC(CC2)=O)=O)C(C3=C(N)C([2H])=C([2H])C([2H])=C31)=O
Biological Activity: Pomalidomide-d3 is the deuterium labeled Pomalidomide. Pomalidomide, the third-generation immunomodulatory agent, acts as molecular glue. Pomalidomide interacts with the E3 ligase cereblon and induces degradation of essential Ikaros transcription factors[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Pomalidomide-d3 | 99.0% | Pomalidomide-d3 is the deuterium labeled Pomalidomide. Pomalidomide, the third-generation immunomodulatory agent, acts as molecular glue. Pomalidomide interacts with the E3 ligase cereblon and induces degradation of essential Ikaros transcription factors. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pomalidomide (Standard) | 99.72% | Pomalidomide (Standard) is the analytical standard of Pomalidomide. This product is intended for research and analytical applications. Pomalidomide, the third-generation immunomodulatory agent, acts as molecular glue. Pomalidomide interacts with the E3 ligase cereblon and induces degradation of essential Ikaros transcription factors. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pomalidomide-d4 | 96.38% | Pomalidomide-d4 is the deuterium labeled Pomalidomide. Pomalidomide, the third-generation immunomodulatory agent, acts as molecular glue. Pomalidomide interacts with the E3 ligase cereblon and induces degradation of essential Ikaros transcription factors< | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pomalidomide-13C5 | Pomalidomide-13C5 (CC-4047-13C5) is 13C labeled Pomalidomide. Pomalidomide, the third-generation immunomodulatory agent, acts as molecular glue. Pomalidomide interacts with the E3 ligase cereblon and induces degradation of essential Ikaros transcription factors. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pomalidomide-d5 | Pomalidomide-d5 is deuterium labeled Pomalidomide. Pomalidomide, the third-generation immunomodulatory agent, acts as molecular glue. Pomalidomide interacts with the E3 ligase cereblon and induces degradation of essential Ikaros transcription factors. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pomalidomide-15N,13C5 | Pomalidomide-15N,13C5 is 15N and 13C labeled Pomalidomide (HY-10984). Pomalidomide, the third-generation immunomodulatory agent, acts as molecular glue. Pomalidomide interacts with the E3 ligase cereblon and induces degradation of essential Ikaros transcription factors. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pomalidomide | 99.88% | Pomalidomide, the third-generation immunomodulatory agent, acts as molecular glue. Pomalidomide interacts with the E3 ligase cereblon and induces degradation of essential Ikaros transcription factors. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief]
- [2]. Zhu YX, et al. Molecular mechanism of action of the immune-modulatory drugs, thalidomide, lenalidomide and pomalidomide in multiple myeloma. Leuk Lymphoma. 2013 Apr;54(4):683-7. [Content Brief]
